MedTrace Logo

Effect of EverVita Pro, a Protein Rich Ingredient, on Satiety Measures, Subsequent Energy Intake, and Gastrointestinal Symptoms: A Randomized, Controlled, Cross-over Study in Healthy Subjects

NCT04869215 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-07-28

No results posted yet for this study

Summary

This study will explore the satiating effect of EverVita Pro when consumed at breakfast on subsequent food intake. On 2 separate days, subjects will consume in random order a test breakfast (bread, butter, jam), either containing containing EverVita Pro or not (control), followed by an ad libitum pizza lunch 1.5 hours later. Before breakfast, after breakfast and after the pizza, subjects will fill in questionnaires regarding their motivation to eat (feelings of hunger/fullness). The hypothesis is that the EverVita Pro breakfast will result in less pizza consumption and prolonged feeling of fullness and satiety in comparison to the control bread.

Conditions

  • Satiety of High Fiber High Protein Bread

Interventions

OTHER

EverVita Pro

EverVita Pro is composed of barley and corn, grown and mechanically processed in Europe, with non-GMO grains.

OTHER

Control bread

Bread baked with normal Bakers flour

Sponsors & Collaborators

  • INQUIS Clinical Research

    collaborator INDUSTRY

  • Evergrain, LLC

    lead INDUSTRY

Principal Investigators

  • Thomas Wolever, DM, PhD · INQUIS Clinical Research

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-22
Primary Completion
2021-09-17
Completion
2021-09-17

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04869215 on ClinicalTrials.gov